Crow J W, Gibaldi M, Levy G
J Pharm Sci. 1979 Oct;68(10):1309-12. doi: 10.1002/jps.2600681030.
The purpose of this investigation was to determine if the previously demonstrated inhibitory effect of phenobarbital treatment on the systemic availability of orally administered dicumarol in rats is related to the known effect of phenobarbital on bile output. It was found that phenobarbital had no apparent effect on the systemic availability of an aqueous dicumarol suspension in rats with ligated bile ducts. Compared to results obtained previously on normal rats, bile duct-ligated rats absorbed and eliminated dicumarol much more slowly and absorbed much less of the anticoagulant. On the other hand, the relative inductive effect of phenobarbital treatment on dicumarol elimination was similar in normal and in bile duct-ligated animals. The latter exhibited substantial serum transaminase elevations, indicative of liver damage presumably secondary to cholestasis. These results demonstrate that a drug-drug interaction can depend markedly on the pathophysiological status of the animals.
本研究的目的是确定先前证明的苯巴比妥治疗对大鼠口服双香豆素全身可用性的抑制作用是否与苯巴比妥对胆汁分泌的已知作用有关。研究发现,苯巴比妥对胆管结扎大鼠的双香豆素水悬浮液的全身可用性没有明显影响。与先前在正常大鼠上获得的结果相比,胆管结扎大鼠吸收和消除双香豆素的速度要慢得多,且抗凝剂的吸收量要少得多。另一方面,苯巴比妥治疗对双香豆素消除的相对诱导作用在正常动物和胆管结扎动物中相似。后者血清转氨酶显著升高,表明可能继发于胆汁淤积的肝损伤。这些结果表明,药物相互作用可能明显取决于动物的病理生理状态。